These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1443022)

  • 1. Posterior segment changes in membranoproliferative glomerulonephritis.
    Kim DD; Mieler WF; Wolf MD
    Am J Ophthalmol; 1992 Nov; 114(5):593-9. PubMed ID: 1443022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.
    Ulbig MR; Riordan-Eva P; Holz FG; Rees HC; Hamilton PA
    Am J Ophthalmol; 1993 Oct; 116(4):410-3. PubMed ID: 8213970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular impairment during type II membranoproliferative glomerulonephritis].
    Lahbil D; Rais L; Hamdani M; El Kettani A; Laouissi N; Zaghloul K; Amraoui A
    J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography of fundus abnormalities associated with type II membranoproliferative glomerulonephritis.
    Batioğlu F; Müftüoğlu O; Atmaca L
    Retina; 2003 Apr; 23(2):261-2. PubMed ID: 12707615
    [No Abstract]   [Full Text] [Related]  

  • 5. Subretinal fluid associated with membranoproliferative glomerulonephritis type 2.
    Polk TD; Kimura AE; Park D; Gass JD
    Arch Ophthalmol; 1997 Jul; 115(7):927-8. PubMed ID: 9230841
    [No Abstract]   [Full Text] [Related]  

  • 6. Fundus changes in type III membranoproliferative glomerulonephritis: a case report.
    Takei M; Obana A; Inomata T; Tanaka T; Shiang T; Bae Y; Takemura T; Murakami A
    BMC Ophthalmol; 2018 Mar; 18(1):72. PubMed ID: 29510686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2.
    Adhi M; Read SP; Liu JJ; Fujimoto JG; Duker JS
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):614-7. PubMed ID: 25423645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients.
    Leys A; Vanrenterghem Y; Van Damme B; Snyers B; Pirson Y; Leys M
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):406-10. PubMed ID: 1937071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundus changes in chronic membranoproliferative glomerulonephritis type II.
    Michielsen B; Leys A; Van Damme B; Missotten L
    Doc Ophthalmol; 1990-1991; 76(3):219-29. PubMed ID: 2103524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II.
    Leys A; Michielsen B; Leys M; Vanrenterghem Y; Missotten L; Van Damme B
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):499-504. PubMed ID: 2265764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings.
    Duvall-Young J; Short CD; Raines MF; Gokal R; Lawler W
    Br J Ophthalmol; 1989 Nov; 73(11):900-6. PubMed ID: 2605144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal function abnormalities in membranoproliferative glomerulonephritis type II.
    Kim RY; Faktorovich EG; Kuo CY; Olson JL
    Am J Ophthalmol; 1997 May; 123(5):619-28. PubMed ID: 9152067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities.
    O'Brien C; Duvall-Young J; Brown M; Short C; Bone M
    Br J Ophthalmol; 1993 Dec; 77(12):778-80. PubMed ID: 8110672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retinochoroidal involvement of type II membranoproliferative glomerulonephritis. An angiographic study with indocyanine green].
    Parrat E; Arndt CF; Labalette P; Boulanger E; Hache JC; Constantinides G; Dequiedt P
    J Fr Ophtalmol; 1997; 20(6):430-8. PubMed ID: 9296039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific eye fundus lesions in type II membranoproliferative glomerulonephritis.
    Leys A; Proesmans W; Van Damme-Lombaerts R; Van Damme B
    Pediatr Nephrol; 1991 Mar; 5(2):189-92. PubMed ID: 2031833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration.
    Del Priore LV; Kaplan HJ; Hornbeck R; Jones Z; Swinn M
    Am J Ophthalmol; 1996 Nov; 122(5):629-43. PubMed ID: 8909202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundus changes in mesangiocapillary glomerulonephritis type II: vitreous fluorophotometry.
    Raines MF; Duvall-Young J; Short CD
    Br J Ophthalmol; 1989 Nov; 73(11):907-10. PubMed ID: 2605145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal manifestations in patients with complement-mediated membranoproliferative glomerulonephritis.
    de-Pablo-Gómez-de-Liaño L; Cañas Zamarra I; Fernández-Vigo JI; Fernández Vidal M; Navarro-Perea C; Cavero Escribano T
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Feb; 94(2):95-99. PubMed ID: 30078750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease.
    Song D; Mohammed I; Bhuyan R; Miwa T; Williams AL; Gullipalli D; Sato S; Song Y; Dunaief JL; Song WC
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3405-3415. PubMed ID: 30025090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral macular drusen in acquired partial lipodystrophy with type 2 membranoproliferative glomerulonephritis.
    Tanner A; Chan HW; Stears A; Moosajee M
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34155011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.